Mirvaso (mer-VAY-soe) is a new brimonidine gel for rosacea

November 2013

Mirvaso (mer-VAY-soe) is a new brimonidine gel for rosacea.

We usually think of brimonidine as an eye drop for glaucoma.

But now brimonidine's vasoconstrictor effects are being used to reduce facial redness due to rosacea.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter membership benefits include:

12 issues every year — what you need to know and do, right now
Quick, practical reference charts and tools
Comprehensive CE library to meet license renewal and state requirements
Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
Plus much more!

Choose the right tier for your needs today.

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Table of Contents

Quality Measures More payers will recognize the value of pharmacists in improving the quality of patient care
Heart Failure bigger emphasis on preventing hospital admissions for heart failure
Diabetes Experts will debate whether gliptins (Onglyza, etc) increase cardiovascular risk in patients with type 2 diabetes
Contraceptives The new Minastrin 24 Fe and Lo Minastrin Fe (min-NASS-trin, norethindrone/ethinyl estradiol) are causing lots of confusion
Supplements whether the probiotic Cardioviva (CAR-dee-oh-VEE-vuh) lowers cholesterol
Substance Use Disorder new approaches to managing alcohol dependence
Dermatology Mirvaso (mer-VAY-soe) is a new brimonidine gel for rosacea
Pregnancy more questions about which cough, cold, and allergy meds to use during pregnancy and breastfeeding
Women's Health Reps will promote Brisdelle (BRIS-del) as a new nonhormonal treatment for hot flashes
Antithrombotics how to manage antiplatelet therapy in patients already taking anticoagulants
Pediatrics many parents exhibit signs of "fever phobia" and overuse antipyretics in their kids